FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003409093> ?p ?o ?g. }

• W2003409093 endingPage "776" @default.
• W2003409093 startingPage "769" @default.
• W2003409093 abstract "Recent large-scale prospective studies suggest that long telomeres are associated with an increase cancer risk, counter to conventional wisdom. To further clarify the association between leukocyte telomere length (LTL) and prostate cancer, and assess genetic variability in relation to both LTL and prostate cancer, we performed a nested case–control study (922 cases and 935 controls). The participants provided blood in 1993–1995 and were followed through August 2004 (prostate cancer incidence) or until 28 February 2013 (lethal or fatal prostate cancer). Relative LTL was measured by quantitative PCR and was calculated as the ratio of telomere repeat copy number to a single gene (36B4) copy number (T/S). Genotyping was performed using the TaqMan OpenArray SNP Genotyping Platform. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) of all prostate cancer and subtypes defined by Gleason grade, stage and lethality (metastasis or death). We observed a positive association between each s.d. increase in LTL and all (multivariable-adjusted OR 1.11, 95% CI: 1.01–1.22), low-grade (OR 1.13, 95% CI:1.01–1.27), and localised (OR 1.12, 95% CI:1.01–1.24) prostate cancer. Associations for other subtypes were similar, but did not reach statistical significance. In subgroup analyses, associations for high grade and advanced stage (OR=2.04, 95% CI 1.00–4.17; Pinteraction=0.06) or lethal disease (OR=2.37, 95% CI 1.19–4.72; Pinteraction=0.01) were stronger in men with a family history of the disease compared with those without. The minor allele of SNP, rs7726159, which has previously been shown to be positively associated with LTL, showed an inverse association with all prostate cancer risk after correction for multiple testing (P=0.0005). In this prospective study, longer LTL was modestly associated with higher risk of prostate cancer. A stronger association for more aggressive cancer in men with a family history of the disease needs to be confirmed in larger studies." @default.
• W2003409093 created "2016-06-24" @default.
• W2003409093 creator A5016971711 @default.
• W2003409093 creator A5024041740 @default.
• W2003409093 creator A5028865365 @default.
• W2003409093 creator A5038373228 @default.
• W2003409093 creator A5049891011 @default.
• W2003409093 creator A5052384074 @default.
• W2003409093 creator A5053312423 @default.
• W2003409093 creator A5058319850 @default.
• W2003409093 date "2015-01-06" @default.
• W2003409093 modified "2023-10-09" @default.
• W2003409093 title "Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer" @default.
• W2003409093 cites W1507422322 @default.
• W2003409093 cites W1529074796 @default.
• W2003409093 cites W1965364326 @default.
• W2003409093 cites W1979833091 @default.
• W2003409093 cites W2014000186 @default.
• W2003409093 cites W2019365015 @default.
• W2003409093 cites W2024809912 @default.
• W2003409093 cites W2031230149 @default.
• W2003409093 cites W2037762348 @default.
• W2003409093 cites W2056176559 @default.
• W2003409093 cites W2063993913 @default.
• W2003409093 cites W2068211792 @default.
• W2003409093 cites W2080035188 @default.
• W2003409093 cites W2091500391 @default.
• W2003409093 cites W2093427603 @default.
• W2003409093 cites W2097870615 @default.
• W2003409093 cites W2100555170 @default.
• W2003409093 cites W2103132669 @default.
• W2003409093 cites W2106675244 @default.
• W2003409093 cites W2107317953 @default.
• W2003409093 cites W2113307719 @default.
• W2003409093 cites W2113904477 @default.
• W2003409093 cites W2119457036 @default.
• W2003409093 cites W2132117845 @default.
• W2003409093 cites W2132899449 @default.
• W2003409093 cites W2133857310 @default.
• W2003409093 cites W2137818078 @default.
• W2003409093 cites W2152915426 @default.
• W2003409093 cites W2153338283 @default.
• W2003409093 cites W2160621707 @default.
• W2003409093 cites W2167285829 @default.
• W2003409093 cites W2170250588 @default.
• W2003409093 cites W2325725181 @default.
• W2003409093 cites W2468052951 @default.
• W2003409093 doi "https://doi.org/10.1038/bjc.2014.640" @default.
• W2003409093 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4333493" @default.
• W2003409093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25562437" @default.
• W2003409093 hasPublicationYear "2015" @default.
• W2003409093 type Work @default.
• W2003409093 sameAs 2003409093 @default.
• W2003409093 citedByCount "68" @default.
• W2003409093 countsByYear W20034090932015 @default.
• W2003409093 countsByYear W20034090932016 @default.
• W2003409093 countsByYear W20034090932017 @default.
• W2003409093 countsByYear W20034090932018 @default.
• W2003409093 countsByYear W20034090932019 @default.
• W2003409093 countsByYear W20034090932020 @default.
• W2003409093 countsByYear W20034090932021 @default.
• W2003409093 countsByYear W20034090932022 @default.
• W2003409093 countsByYear W20034090932023 @default.
• W2003409093 crossrefType "journal-article" @default.
• W2003409093 hasAuthorship W2003409093A5016971711 @default.
• W2003409093 hasAuthorship W2003409093A5024041740 @default.
• W2003409093 hasAuthorship W2003409093A5028865365 @default.
• W2003409093 hasAuthorship W2003409093A5038373228 @default.
• W2003409093 hasAuthorship W2003409093A5049891011 @default.
• W2003409093 hasAuthorship W2003409093A5052384074 @default.
• W2003409093 hasAuthorship W2003409093A5053312423 @default.
• W2003409093 hasAuthorship W2003409093A5058319850 @default.
• W2003409093 hasBestOaLocation W20034090931 @default.
• W2003409093 hasConcept C104317684 @default.
• W2003409093 hasConcept C121608353 @default.
• W2003409093 hasConcept C126322002 @default.
• W2003409093 hasConcept C135763542 @default.
• W2003409093 hasConcept C143998085 @default.
• W2003409093 hasConcept C156957248 @default.
• W2003409093 hasConcept C165617652 @default.
• W2003409093 hasConcept C2780192828 @default.
• W2003409093 hasConcept C31467283 @default.
• W2003409093 hasConcept C54355233 @default.
• W2003409093 hasConcept C71924100 @default.
• W2003409093 hasConcept C86803240 @default.
• W2003409093 hasConceptScore W2003409093C104317684 @default.
• W2003409093 hasConceptScore W2003409093C121608353 @default.
• W2003409093 hasConceptScore W2003409093C126322002 @default.
• W2003409093 hasConceptScore W2003409093C135763542 @default.
• W2003409093 hasConceptScore W2003409093C143998085 @default.
• W2003409093 hasConceptScore W2003409093C156957248 @default.
• W2003409093 hasConceptScore W2003409093C165617652 @default.
• W2003409093 hasConceptScore W2003409093C2780192828 @default.
• W2003409093 hasConceptScore W2003409093C31467283 @default.
• W2003409093 hasConceptScore W2003409093C54355233 @default.
• W2003409093 hasConceptScore W2003409093C71924100 @default.
• W2003409093 hasConceptScore W2003409093C86803240 @default.
• W2003409093 hasIssue "4" @default.

• next